ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +7.7% | 0 | -100.0% | 0.00% | – |
| Q2 2022 | $13,000 | -13.3% | 580 | 0.0% | 0.00% | – |
| Q1 2022 | $15,000 | -28.6% | 580 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -16.0% | 580 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | 0.0% | 580 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -10.7% | 580 | -14.5% | 0.00% | – |
| Q1 2021 | $28,000 | -37.8% | 678 | -32.2% | 0.00% | – |
| Q4 2020 | $45,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | -7.9% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $38,000 | +31.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -44.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $52,000 | -64.9% | 1,000 | -63.0% | 0.00% | – |
| Q3 2019 | $148,000 | -81.6% | 2,700 | -86.4% | 0.00% | – |
| Q2 2019 | $804,000 | +3920.0% | 19,800 | +3200.0% | 0.00% | – |
| Q4 2018 | $20,000 | -33.3% | 600 | -14.3% | 0.00% | – |
| Q3 2018 | $30,000 | -6.2% | 700 | -30.0% | 0.00% | – |
| Q2 2018 | $32,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |